ANGO
Price
$10.73
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
436M
25 days until earnings call
BLFS
Price
$26.46
Change
+$0.59 (+2.28%)
Updated
Sep 5 closing price
Capitalization
1.27B
60 days until earnings call
Interact to see
Advertisement

ANGO vs BLFS

Header iconANGO vs BLFS Comparison
Open Charts ANGO vs BLFSBanner chart's image
AngioDynamics
Price$10.73
Change-$0.00 (-0.00%)
Volume$277.3K
Capitalization436M
BioLife Solutions
Price$26.46
Change+$0.59 (+2.28%)
Volume$314.44K
Capitalization1.27B
ANGO vs BLFS Comparison Chart in %
Loading...
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANGO vs. BLFS commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a StrongBuy and BLFS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ANGO: $10.73 vs. BLFS: $26.46)
Brand notoriety: ANGO and BLFS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANGO: 51% vs. BLFS: 62%
Market capitalization -- ANGO: $436M vs. BLFS: $1.27B
ANGO [@Pharmaceuticals: Other] is valued at $436M. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANGO’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • ANGO’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than ANGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANGO’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 6 bullish TA indicator(s).

  • ANGO’s TA Score: 5 bullish, 6 bearish.
  • BLFS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than ANGO.

Price Growth

ANGO (@Pharmaceuticals: Other) experienced а +4.58% price change this week, while BLFS (@Pharmaceuticals: Other) price change was +5.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

ANGO is expected to report earnings on Oct 02, 2025.

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.27B) has a higher market cap than ANGO($436M). ANGO YTD gains are higher at: 17.140 vs. BLFS (1.926). BLFS has higher annual earnings (EBITDA): 17.4M vs. ANGO (1.74M). BLFS has more cash in the bank: 81.8M vs. ANGO (55.9M). ANGO has less debt than BLFS: ANGO (5M) vs BLFS (23.8M). ANGO has higher revenues than BLFS: ANGO (292M) vs BLFS (93.5M).
ANGOBLFSANGO / BLFS
Capitalization436M1.27B34%
EBITDA1.74M17.4M10%
Gain YTD17.1401.926890%
P/E RatioN/AN/A-
Revenue292M93.5M312%
Total Cash55.9M81.8M68%
Total Debt5M23.8M21%
FUNDAMENTALS RATINGS
ANGO vs BLFS: Fundamental Ratings
ANGO
BLFS
OUTLOOK RATING
1..100
4517
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
9489
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
4244
P/E GROWTH RATING
1..100
5714
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANGO's Valuation (68) in the Medical Specialties industry is in the same range as BLFS (99). This means that ANGO’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (89) in the Medical Specialties industry is in the same range as ANGO (94). This means that BLFS’s stock grew similarly to ANGO’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as ANGO (96). This means that BLFS’s stock grew similarly to ANGO’s over the last 12 months.

ANGO's Price Growth Rating (42) in the Medical Specialties industry is in the same range as BLFS (44). This means that ANGO’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for ANGO (57). This means that BLFS’s stock grew somewhat faster than ANGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANGOBLFS
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 28 days ago
72%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ANGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVRIX28.000.21
+0.76%
VY® CBRE Real Estate I
GQSCX14.740.08
+0.55%
Glenmede Disciplined US Small Cap Eq Ptf
OLVRX21.91N/A
N/A
JPMorgan Large Cap Value R4
BBLIX17.14N/A
N/A
BBH Select Series - Large Cap
CBAIX48.91-0.01
-0.02%
Calvert Balanced I

ANGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with MXCT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANGO
1D Price
Change %
ANGO100%
N/A
MXCT - ANGO
36%
Loosely correlated
+3.68%
BLFS - ANGO
33%
Poorly correlated
+2.28%
RGEN - ANGO
32%
Poorly correlated
+3.30%
FLGT - ANGO
32%
Poorly correlated
-0.14%
ABT - ANGO
32%
Poorly correlated
+0.10%
More